<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Randomize klinik çalışma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/randomize-klinik-calisma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 13:46:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Randomize klinik çalışma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Comparing Buprenorphine Forms in Jail Study</title>
		<link>https://bioengineer.org/comparing-buprenorphine-forms-in-jail-study/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 13:46:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Hapishane Sağlık Hizmetleri]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Buprenorfin Tedavisi]]></category>
		<category><![CDATA[iki farklı buprenorfin formunun karşıla]]></category>
		<category><![CDATA[İlaç Uyumu** * **Buprenorfin Tedavisi:** Makalenin ana konusu]]></category>
		<category><![CDATA[İşte 5 uygun etiket]]></category>
		<category><![CDATA[Opioid Kullanım Bozukluğu]]></category>
		<category><![CDATA[Randomize klinik çalışma]]></category>
		<category><![CDATA[Uzun Salınımlı Buprenorfin** **Açıklama:** 1. **Buprenorfin Tedav]]></category>
		<category><![CDATA[virgülle ayrılmış olarak: **Buprenorfin Tedavisi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/comparing-buprenorphine-forms-in-jail-study/</guid>

					<description><![CDATA[In the field of addiction medicine, the exploration of effective treatment modalities for individuals grappling with substance use disorders remains a pressing issue. New research led by Rottapel, Stopka, and Friedmann proposes a comprehensive protocol for a randomized clinical trial aimed at comparing two prominent formulations of buprenorphine: extended-release and sublingual. This study targets a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319828</post-id>	</item>
		<item>
		<title>Tuina vs. Physiotherapy: Pain Management in Chronic Back Pain</title>
		<link>https://bioengineer.org/tuina-vs-physiotherapy-pain-management-in-chronic-back-pain/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 16:32:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Ağrı Yönetimi]]></category>
		<category><![CDATA[Ağrı yönetimi stratejileri]]></category>
		<category><![CDATA[Fizyoterapi]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **Kronik Bel Ağrısı]]></category>
		<category><![CDATA[İşte bu içerik için uygun 5 etiket (virgülle ayrılmış): **Kronik bel ağrısı tedavisi]]></category>
		<category><![CDATA[Randomize klinik çalışma]]></category>
		<category><![CDATA[Randomize Klinik Çalışma** **Açıklama:** 1. **Kronik Bel Ağrısı:** Yazının ana konusu ve araştırmanın odak noktasıdır. 2. **]]></category>
		<category><![CDATA[Tamamlayıcı tıp uygulamaları** **Açıklama:** 1. **Kron]]></category>
		<category><![CDATA[Tuina Terapisi]]></category>
		<category><![CDATA[Tuina vs fizyoterapi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tuina-vs-physiotherapy-pain-management-in-chronic-back-pain/</guid>

					<description><![CDATA[A recent study led by a team of researchers, including Tan, Wong, and Qiao, shifted the spotlight on chronic low back pain, a condition that plagues millions of individuals worldwide. As the prevalence of chronic low back pain escalates, there is an urgent need for effective treatment modalities. This investigative effort explored the effectiveness of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315356</post-id>	</item>
		<item>
		<title>Empagliflozin’s Impact on Liver Health in Diabetes</title>
		<link>https://bioengineer.org/empagliflozins-impact-on-liver-health-in-diabetes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 28 Nov 2025 21:55:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Diyabet ilaçlarının hepatik etkileri]]></category>
		<category><![CDATA[Empagliflozin ve karaciğer sağlığı]]></category>
		<category><![CDATA[Karaciğer fibrozu tedavisi]]></category>
		<category><![CDATA[Randomize klinik çalışma]]></category>
		<category><![CDATA[Tip 2 diyabet ve NAFLD]]></category>
		<guid isPermaLink="false">https://bioengineer.org/empagliflozins-impact-on-liver-health-in-diabetes/</guid>

					<description><![CDATA[Recent advancements in the field of diabetes management have led to promising innovations, particularly concerning the treatment of Type 2 diabetes patients suffering from non-alcoholic fatty liver disease (NAFLD). A pivotal study by Erfanifar et al. has shed new light on the effects of empagliflozin, a medication primarily known for its glucose-lowering properties, on liver [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">303032</post-id>	</item>
	</channel>
</rss>
